A Cohort Study to Evaluate the Efficacy of Early versus Delayed Roflumilast Therapy on Exacerbation rate, Disease severity and Comorbidities in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Trial Profile

A Cohort Study to Evaluate the Efficacy of Early versus Delayed Roflumilast Therapy on Exacerbation rate, Disease severity and Comorbidities in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Aug 2015

At a glance

  • Drugs Roflumilast (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top